Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
79 /100
CRITICAL RISK
Score updated Oct 13, 2026

ESLA — Estrella Immunopharma, Inc. Dilution Risk Tracker

Track ESLA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ESLA — Get alerts when the score changes →

As of October 13, 2026, Estrella Immunopharma, Inc. (ESLA) has a DilutionWatch DilutionScore of 79/100, rated CRITICAL dilution risk. Estrella Immunopharma, Inc. has a market capitalization of $14.31M, 43.50M shares outstanding. Stored dilution-related fields include 2.21M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
62
💰 Cash Runway
95
📊 Float Risk
62
⚠️ Warrant Exposure
30
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 44%
💰 Capital Raise model 55%
• Critical: only 0.1 months cash remaining
🔄 Reverse Split model est. 45%
• 50-day avg $1.37 approaching $1 threshold
• Only 0 months cash — financial pressure
📜 Warrant Exercise model 15%
• Warrant overhang: 5.1% of shares outstanding
🔔 Track ESLA — Get forecast alerts →

Market Data

Market Cap$14.31M
Shares Outstanding43.50M
Float14.11M
Cash$100.0K
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore79/100DilutionWatch score record
Shares Outstanding43.50MVerified float table or market cache
Public Float14.11MVerified float table or market cache
Market Cap$14.31MMarket data cache
Cash Runway0.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants2.21MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

11.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track ESLA for full holder detail →

Short Interest

Short Interest214.0K
Days to Cover4.7
% of Float1.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2023-08-01
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ESLA Dilution Snapshot

Estrella Immunopharma, Inc. (ESLA) has a DilutionScore of 79/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ESLA's DilutionScore is currently 79/100 (Critical risk), with 1 score change tracked over 89 days. The score deteriorated from 84/100 (Critical risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202679/100CRITICAL16 days
Jul 16 – Sep 27, 202684/100CRITICAL73 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ESLA shares outstanding have increased 2.4% from 42.03M (Mar 2026) to 43.03M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 26, 202643.03M14.11M▲ 1.80%
May 25, 202643.03M13.86M▼ 1.30%
May 20, 202643.03M14.04M▲ 0.86%
May 18, 202642.67M13.92M▼ 22.74%
Mar 26, 202642.67M18.02M▲ 2.10%
Mar 19, 202642.03M17.65M▲ 12.97%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ESLA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ESLA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ESLA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ESLA
ESLA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.